Virus-specific T cells may predict immunotherapy success for a rare brain infection

Progressive multifocal leukoencephalopathy (PML) is a rare but serious brain infection. It gradually destroys brain tissue and often leads to death within a few weeks. It is triggered by human polyomavirus 2, also known as John Cunningham (JC) virus. PML primarily affects people with weakened immune cells, especially T lymphocytes.